aluates Reports

$ 0.0

Automative

Global Drugs for Osteoarthritis Pain Market Research Report 2026

Published Date: 2026-03-27

Report Code: QYRE-Auto-31D9048

Global Drugs for Osteoarthritis Pain Market Insights and Forecast to 2028

BUY CHAPTERS

Global Drugs for Osteoarthritis Pain Market Research Report 2026

Code: QYRE-Auto-31D9048

Report

2026-03-27

Pages:121

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Sanofi

Horizon Pharma

Abbott

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Pfizer Inc

GlaxoSmithKline PLC

Bayer

Eli Lilly

Novartis

Mylan NV

Daiichi Sankyo

Johnson & Johnson

Drugs for Osteoarthritis Pain Market Size

The global Drugs for Osteoarthritis Pain market was valued at US$ 10900 million in 2025 and is anticipated to reach US$ 16190 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Drugs for Osteoarthritis Pain Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

This report delivers a comprehensive overview of the global Drugs for Osteoarthritis Pain market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs for Osteoarthritis Pain. The Drugs for Osteoarthritis Pain market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drugs for Osteoarthritis Pain market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drugs for Osteoarthritis Pain manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drugs for Osteoarthritis Pain Market Report

Report Metric	Details
Report Name	Drugs for Osteoarthritis Pain Market
Accounted market size in 2025	US$ 10900 million
Forecasted market size in 2032	US$ 16190 million
CAGR	5.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Injection External
Segment by Application	Medical Care Personal Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drugs for Osteoarthritis Pain companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drugs for Osteoarthritis Pain Market growing?

Ans: The Drugs for Osteoarthritis Pain Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Drugs for Osteoarthritis Pain Market size in 2032?

Ans: The Drugs for Osteoarthritis Pain Market size in 2032 will be US$ 16190 million.

What is the Drugs for Osteoarthritis Pain Market share by region?

Ans: North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

What is the market share of major companies in Drugs for Osteoarthritis Pain Market?

Ans: Top 5 companies occupied about 66% market share.

Who are the main players in the Drugs for Osteoarthritis Pain Market report?

Ans: The main players in the Drugs for Osteoarthritis Pain Market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma

What are the Application segmentation covered in the Drugs for Osteoarthritis Pain Market report?

Ans: The Applications covered in the Drugs for Osteoarthritis Pain Market report are Medical Care, Personal Care

What are the Type segmentation covered in the Drugs for Osteoarthritis Pain Market report?

Ans: The Types covered in the Drugs for Osteoarthritis Pain Market report are Oral, Injection, External

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market by Application

1.3.1 Global Drugs for Osteoarthritis Pain Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2021–2032)

2.2 Global Drugs for Osteoarthritis Pain Growth Trends by Region

2.2.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2021–2026)

2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2027–2032)

2.3 Drugs for Osteoarthritis Pain Market Dynamics

2.3.1 Drugs for Osteoarthritis Pain Industry Trends

2.3.2 Drugs for Osteoarthritis Pain Market Drivers

2.3.3 Drugs for Osteoarthritis Pain Market Challenges

2.3.4 Drugs for Osteoarthritis Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue

3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2021–2026)

3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2021–2026)

3.2 Global Top Drugs for Osteoarthritis Pain Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drugs for Osteoarthritis Pain Revenue

3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio

3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2025

3.5 Global Key Players of Drugs for Osteoarthritis Pain Head Offices and Areas Served

3.6 Global Key Players of Drugs for Osteoarthritis Pain, Products and Applications

3.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drugs for Osteoarthritis Pain Breakdown Data by Type

4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2021–2026)

4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2027–2032)

5 Drugs for Osteoarthritis Pain Breakdown Data by Application

5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2021–2026)

5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drugs for Osteoarthritis Pain Market Size (2021–2032)

6.2 North America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2021–2026)

6.4 North America Drugs for Osteoarthritis Pain Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Osteoarthritis Pain Market Size (2021–2032)

7.2 Europe Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2021–2026)

7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Osteoarthritis Pain Market Size (2021–2032)

8.2 Asia-Pacific Drugs for Osteoarthritis Pain Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2021–2026)

8.4 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drugs for Osteoarthritis Pain Market Size (2021–2032)

9.2 Latin America Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2021–2026)

9.4 Latin America Drugs for Osteoarthritis Pain Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Osteoarthritis Pain Market Size (2021–2032)

10.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2021–2026)

10.4 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction

11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction

11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.2.5 Johnson & Johnson Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction

11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.3.5 GlaxoSmithKline Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction

11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.4.5 Bayer Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction

11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.5.5 Eli Lilly Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction

11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.6.5 Novartis Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction

11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.7.5 Sanofi Recent Development

11.8 Horizon Pharma

11.8.1 Horizon Pharma Company Details

11.8.2 Horizon Pharma Business Overview

11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction

11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.8.5 Horizon Pharma Recent Development

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction

11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.9.5 Abbott Recent Development

11.10 Mylan

11.10.1 Mylan Company Details

11.10.2 Mylan Business Overview

11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction

11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.10.5 Mylan Recent Development

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Details

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction

11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.11.5 Daiichi Sankyo Recent Development

11.12 TEVA

11.12.1 TEVA Company Details

11.12.2 TEVA Business Overview

11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction

11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.12.5 TEVA Recent Development

11.13 Almatica Pharma

11.13.1 Almatica Pharma Company Details

11.13.2 Almatica Pharma Business Overview

11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction

11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.13.5 Almatica Pharma Recent Development

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Details

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction

11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.14.5 Astellas Pharma Recent Development

11.15 Tide Pharmaceutical

11.15.1 Tide Pharmaceutical Company Details

11.15.2 Tide Pharmaceutical Business Overview

11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction

11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.15.5 Tide Pharmaceutical Recent Development

11.16 Iroko Pharmaceuticals

11.16.1 Iroko Pharmaceuticals Company Details

11.16.2 Iroko Pharmaceuticals Business Overview

11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction

11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.16.5 Iroko Pharmaceuticals Recent Development

11.17 Hengrui Pharmaceutical

11.17.1 Hengrui Pharmaceutical Company Details

11.17.2 Hengrui Pharmaceutical Business Overview

11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction

11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.17.5 Hengrui Pharmaceutical Recent Development

11.18 Abiogen Pharma

11.18.1 Abiogen Pharma Company Details

11.18.2 Abiogen Pharma Business Overview

11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction

11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2021–2026)

11.18.5 Abiogen Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Sanofi

Horizon Pharma

Abbott

TEVA

Almatica Pharma

Astellas Pharma

Tide Pharmaceutical

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Abiogen Pharma

Pfizer Inc

GlaxoSmithKline PLC

Bayer

Eli Lilly

Novartis

Mylan NV

Daiichi Sankyo

Johnson & Johnson

List of Tables

Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Key Players of External

Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (US$ Million), 2021–2026

Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2021–2026)

Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2027–2032)

Table 11. Drugs for Osteoarthritis Pain Market Trends

Table 12. Drugs for Osteoarthritis Pain Market Drivers

Table 13. Drugs for Osteoarthritis Pain Market Challenges

Table 14. Drugs for Osteoarthritis Pain Market Restraints

Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (US$ Million), 2021–2026

Table 16. Global Drugs for Osteoarthritis Pain Market Share by Players (2021–2026)

Table 17. Global Top Drugs for Osteoarthritis Pain Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drugs for Osteoarthritis Pain Revenue, 2025

Table 18. Ranking of Global Top Drugs for Osteoarthritis Pain Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served

Table 21. Global Key Players of Drugs for Osteoarthritis Pain, Products and Applications

Table 22. Global Key Players of Drugs for Osteoarthritis Pain, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (US$ Million), 2021–2026

Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2021–2026)

Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2027–2032)

Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (US$ Million), 2021–2026

Table 29. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2021–2026)

Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2027–2032)

Table 32. North America Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2021–2026

Table 34. North America Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Drugs for Osteoarthritis Pain Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country (US$ Million), 2027–2032

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Drugs for Osteoarthritis Pain Product

Table 50. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 51. Pfizer Recent Development

Table 52. Johnson & Johnson Company Details

Table 53. Johnson & Johnson Business Overview

Table 54. Johnson & Johnson Drugs for Osteoarthritis Pain Product

Table 55. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 56. Johnson & Johnson Recent Development

Table 57. GlaxoSmithKline Company Details

Table 58. GlaxoSmithKline Business Overview

Table 59. GlaxoSmithKline Drugs for Osteoarthritis Pain Product

Table 60. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 61. GlaxoSmithKline Recent Development

Table 62. Bayer Company Details

Table 63. Bayer Business Overview

Table 64. Bayer Drugs for Osteoarthritis Pain Product

Table 65. Bayer Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 66. Bayer Recent Development

Table 67. Eli Lilly Company Details

Table 68. Eli Lilly Business Overview

Table 69. Eli Lilly Drugs for Osteoarthritis Pain Product

Table 70. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 71. Eli Lilly Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Drugs for Osteoarthritis Pain Product

Table 75. Novartis Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 76. Novartis Recent Development

Table 77. Sanofi Company Details

Table 78. Sanofi Business Overview

Table 79. Sanofi Drugs for Osteoarthritis Pain Product

Table 80. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 81. Sanofi Recent Development

Table 82. Horizon Pharma Company Details

Table 83. Horizon Pharma Business Overview

Table 84. Horizon Pharma Drugs for Osteoarthritis Pain Product

Table 85. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 86. Horizon Pharma Recent Development

Table 87. Abbott Company Details

Table 88. Abbott Business Overview

Table 89. Abbott Drugs for Osteoarthritis Pain Product

Table 90. Abbott Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 91. Abbott Recent Development

Table 92. Mylan Company Details

Table 93. Mylan Business Overview

Table 94. Mylan Drugs for Osteoarthritis Pain Product

Table 95. Mylan Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 96. Mylan Recent Development

Table 97. Daiichi Sankyo Company Details

Table 98. Daiichi Sankyo Business Overview

Table 99. Daiichi Sankyo Drugs for Osteoarthritis Pain Product

Table 100. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 101. Daiichi Sankyo Recent Development

Table 102. TEVA Company Details

Table 103. TEVA Business Overview

Table 104. TEVA Drugs for Osteoarthritis Pain Product

Table 105. TEVA Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 106. TEVA Recent Development

Table 107. Almatica Pharma Company Details

Table 108. Almatica Pharma Business Overview

Table 109. Almatica Pharma Drugs for Osteoarthritis Pain Product

Table 110. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 111. Almatica Pharma Recent Development

Table 112. Astellas Pharma Company Details

Table 113. Astellas Pharma Business Overview

Table 114. Astellas Pharma Drugs for Osteoarthritis Pain Product

Table 115. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 116. Astellas Pharma Recent Development

Table 117. Tide Pharmaceutical Company Details

Table 118. Tide Pharmaceutical Business Overview

Table 119. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product

Table 120. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 121. Tide Pharmaceutical Recent Development

Table 122. Iroko Pharmaceuticals Company Details

Table 123. Iroko Pharmaceuticals Business Overview

Table 124. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product

Table 125. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 126. Iroko Pharmaceuticals Recent Development

Table 127. Hengrui Pharmaceutical Company Details

Table 128. Hengrui Pharmaceutical Business Overview

Table 129. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product

Table 130. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 131. Hengrui Pharmaceutical Recent Development

Table 132. Abiogen Pharma Company Details

Table 133. Abiogen Pharma Business Overview

Table 134. Abiogen Pharma Drugs for Osteoarthritis Pain Product

Table 135. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (US$ Million), 2021–2026

Table 136. Abiogen Pharma Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

Table 140. Authors List of This Report

List of Figures

Figure 1. Drugs for Osteoarthritis Pain Picture

Figure 2. Global Drugs for Osteoarthritis Pain Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drugs for Osteoarthritis Pain Market Share by Type: 2025 vs 2032

Figure 4. Oral Features

Figure 5. Injection Features

Figure 6. External Features

Figure 7. Global Drugs for Osteoarthritis Pain Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Drugs for Osteoarthritis Pain Market Share by Application: 2025 vs 2032

Figure 9. Medical Care Case Studies

Figure 10. Personal Care Case Studies

Figure 11. Drugs for Osteoarthritis Pain Report Years Considered

Figure 12. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Drugs for Osteoarthritis Pain Market Share by Region: 2025 vs 2032

Figure 15. Global Drugs for Osteoarthritis Pain Market Share by Players in 2025

Figure 16. Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2025

Figure 18. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Country (2021–2032)

Figure 20. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Drugs for Osteoarthritis Pain Market Share by Country (2021–2032)

Figure 24. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Drugs for Osteoarthritis Pain Market Share by Region (2021–2032)

Figure 32. China Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Drugs for Osteoarthritis Pain Market Share by Country (2021–2032)

Figure 40. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Share by Country (2021–2032)

Figure 44. Israel Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Drugs for Osteoarthritis Pain Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 48. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 50. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 51. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 52. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 53. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 54. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 55. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 56. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 57. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 58. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 59. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 60. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 61. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 62. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 63. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 64. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2021–2026)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Osteoarthritis Drugs Market

Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030

Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Medications Market

Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Osteoarthritis Therapeutics Market Research Report 2024

Spine Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hip Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Osteoarthritis Pain Solution Market Research Report 2024

Global Drugs for Pain Management Market Insights Forecast to 2030

Hip Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spine Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Osteoarthritis Pain Market

Global Postoperative Pain Therapeutics Market Insights Forecast to 2030

Knee Osteoarthritis Treatment Market

Global Pain Treatment Drug Market Research Report 2025

Global Pain Management Drugs Market Research Report 2025

Global Hyaluronic Acid Injections for Joint Pain Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Pain Treatment Medication Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions